Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-finding and Proof-of-concept Trial of Probucol to Increase Availability of CSF Apolipoprotein-E

NCT02707458 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.

NCT NCT02707458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02707458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-finding and Proof-of-concept Trial of Probucol to Increase Availability of CSF Apolipoprotein-E
Lead sponsor
Douglas Mental Health University Institute
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2016
Completion date
March 31, 2017
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related cognitive decline, dementia of the alzheimer type, mild cognitive impairment due to alzheimer disease